Head-to-head · WeighScore
AM Rx vs Semaglutide Online
The verdict
Semaglutide Online takes it — 74.3/100 to 49.6/100.
Semaglutide Online grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Semaglutide Online is a LegitScript-certified telehealth platform prescribing compounded and brand-name GLP-1/GIP medications nationwide (excluding Alabama).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AM Rx | Semaglutide Online |
|---|---|---|
| WeighScore | 49.6/100 | 74.3/100 |
| Grade | C | C |
| Scorecard rank | #491 | #65 |
| Semaglutide | $151/mo (quarterly plan, plus a separate fee, compounded) | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $299/mo (all doses, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #491 · C
Strengths
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- HSA and FSA accepted
- Video visits available with providers averaging 10+ years' experience
- Compounded semaglutide from $151/mo on the quarterly plan
Where it loses points
- Active FTC/DOJ lawsuit over deceptive billing and subscription practices
- Novo Nordisk false-advertising lawsuit (Aug 2025)
- Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
- Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #65 · C
Strengths
- LegitScript certified — passes accreditation standards recognized by Google and Visa for online telehealth
- Compounded all-in pricing: semaglutide $199/mo and tirzepatide $299/mo includes medication, provider care, and shipping
- Brand-name options (Wegovy pill, injectable sema, Zepbound) available for eligible patients, potentially $0-$25/mo with insurance
- Nationwide (49 states + DC); no appointment required, licensed provider reviews intake within 12 hours
- 0% financing through Credee from $79/month (12-24 months) plus Affirm and Klarna with ~97% approval rate
Where it loses points
- No labs or clinical monitoring disclosed — blood work requirements not mentioned anywhere on site
- Leadership team and medical director not identified on site — no named prescribers or company founders published
- Brand-name prescriptions add a $44/month provider fee on top of medication cost, raising total price to $193-$343/mo
- No coaching, dietitian, or behavioral support at any tier — medication and async provider access only
- 30-day satisfaction guarantee covers evaluation fee only; medication costs explicitly non-refundable
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.